Continuous Blood purification on Influenza-Associated Neurological Disease in children: a retrospective cohort study

Table 2 Outcomes of CBP and non-CBP groups

Outcomes	CBP group (n=18)	Non-CBP group (n=12)	p
28-day mortality, n (%)^a	2 (11.11)	6 (50)	0.034*
Glasgow score (median [IQR])^b	7.00 (4.00-7.25)	3.50 (3.00-5.75)	0.021*
PIM-2 score (median [IQR])^b	11.00 (7.78-22.55)	43.80 (9.28-85.03)	0.040*
Critical illness score (median [IQR])^b	93 (88.00-94.00)	81 (77.00-93.50)	0.038*
PICU stay (median [IQR]) (d)^c	19.00 (15.00-22.50)	10.00 (4.00-12.00)	0.008*
Ventilation time (median [IQR]) (d)^c	7.50 (5.75-15.25)	5.50 (4.00-6.75)	0.060
hospitalization costs(median [IQR]) (US dollars)^c	11350.67 (8670.36-16802.95)	6195.63 (3246.95-8000.03)	0.008*

CBP Continuous blood purification, IQR Interquartile range, PIM-2 Pediatric index of mortality 2, PICU Pediatric intensive care unit
^* p<0.05
^a p<0.05 The 28-day mortality using the Chi-squared test
^b p<0.05 The Glasgow score, PIM-2 score, Critical ill score using Mann-Whitney U test
^c p<0.05 The PICU stay, Ventilation time, Hospitalization costs using nonparametric tests/compare medians across groups

ISSN: 1471-2334